NIO
NIO Inc.
NIO has a slight edge over TCOM overall, supported by stronger fundamentals and stronger modeled upside.
TCOM
Trip.com Group Limited
TCOM has lower modeled downside risk, despite its lower overall score.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
TCOM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Strong | |
| Strong |
TCOM's cash flow and balance sheet are currently strong, and its revenue and profitability are stable.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
TCOM PE Valuation
TCOM has no meaningful PE right now: it lost money over the past year.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
NIO has the edge over TCOM on the outlook, with more favorable profitability expectations.
TCOM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for TCOM, with profitability holding steady.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
TCOM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $5.16 | +32% |
| Q1 2026 | $6.79 | +84% |
| Q4 2025 | $7.16 | +91% |
| Q3 2025 | $6.72 | +88% |
| Q2 2025 | $3.91 | +26% |
| Q1 2025 | $3.70 | +53% |
| Q4 2024 | $3.75 | +70% |
| Q3 2024 | $3.57 | +49% |
TCOM has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO's revenue has grown year over year for seven quarters in a row: $4.8B last quarter, up 69% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO has the edge over TCOM on profitability, with a higher operating margin.
TCOM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.4B | +5.5% |
| Q1 2026 | $2.4B | +16% |
| Q4 2025 | $2.3B | +19% |
| Q3 2025 | $2.8B | +16% |
| Q2 2025 | $2.2B | +16% |
| Q1 2025 | $2.1B | +16% |
| Q4 2024 | $1.9B | +23% |
| Q3 2024 | $2.4B | +16% |
TCOM's revenue has grown year over year for 16 quarters in a row: $2.4B last quarter, up 5.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -9.3% | -37 points |
| Q1 2026 | 24% | -1.4 points |
| Q4 2025 | 16% | -1.6 points |
| Q3 2025 | 30% | -1.1 points |
| Q2 2025 | 28% | -0.2 points |
| Q1 2025 | 26% | -2.1 points |
| Q4 2024 | 18% | -3.2 points |
| Q3 2024 | 32% | +3.1 points |
TCOM's operating margin was −9.3% last quarter, down 37 points from the same quarter a year ago.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO has the edge over TCOM on cash flow, with more consistent year-over-year improvement.
TCOM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $2B | +$2B |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | -100% |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | -100% |
TCOM's free cash flow has been positive every quarter for seven years: $2B over the past year, against $0 the year before.
NIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +15.6M shares |
| 1 year | +12% | +267M shares |
| 3 years | +51% | +844M shares |
| 5 years | +60% | +933M shares |
| Available history | +143% | +1.5B shares |
NIO has 2.5B diluted shares, up 12% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NIO hasn't bought back shares in the past year.
TCOM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -7.2% | -49.3M shares |
| 1 year | -9.1% | -63.4M shares |
| 3 years | -5.9% | -39.6M shares |
| 5 years | -0.5% | -3.1M shares |
| Available history | +5.1% | +30.7M shares |
TCOM has the edge over NIO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $659.7M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
TCOM spent $660M buying back its own shares over the past year, after none the year before.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TCOM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.9x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.7x | Net Cash |
| Q2 2025 | -0.8x | Net Cash |
| Q1 2025 | -0.6x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
| Q3 2024 | 0.2x | Very low |
TCOM has more cash than debt.
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
TCOM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.3 | Neutral |
| Stochastic | 49.2 | Neutral |
TCOM's weekly RSI is 47 (neutral) and its Stochastic is 49 (neutral).
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
TCOM PE vs Consumer Cyclical Sector
| Metric | TCOM | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
TCOM has no meaningful PE right now: it lost money over the past year.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
TCOM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $40.4 | 6.9% above |
| 20 week MA | $42.2 | 2.4% above |
| 50 week MA | $50.7 | 15% below |
| 100 week MA | $58.1 | 26% below |
| 200 week MA | $50.6 | 15% below |
TCOM has the edge over NIO on trend strength, trading above more of its moving averages.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO has the edge over TCOM on returns for 2026, with the stronger performance.
TCOM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $34.6 | $32.0 | -7.6% |
| 2021 | $32.0 | $23.8 | -26% |
| 2022 | $23.8 | $34.0 | +43% |
| 2023 | $34.0 | $36.0 | +5.9% |
| 2024 | $36.0 | $70.6 | +96% |
| 2025 | $70.6 | $72.5 | +2.7% |
| 2026 YTD | $72.5 | $43.2 | -40% |
TCOM is down 40% so far in 2026, after finishing higher in four of the previous six years.